Aakaar Medical Technologies Ltd.

NSEI:AAKAAR Stock Report

Market Cap: ₹1.2b

Aakaar Medical Technologies Management

Management criteria checks 1/4

Aakaar Medical Technologies' CEO is Rahul Sawakhande, appointed in Jun 2024, has a tenure of 1.33 years. directly owns 4.1% of the company’s shares, worth ₹48.21M. The average tenure of the management team and the board of directors is 1.3 years and 1.3 years respectively.

Key information

Rahul Sawakhande

Chief executive officer

₹6.3m

Total compensation

CEO salary percentagen/a
CEO tenure1.3yrs
CEO ownership4.1%
Management average tenure1.3yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

Aakaar Medical Technologies (NSE:AAKAAR) Seems To Use Debt Quite Sensibly

Sep 30
Aakaar Medical Technologies (NSE:AAKAAR) Seems To Use Debt Quite Sensibly

CEO

Rahul Sawakhande (45 yo)

1.3yrs
Tenure
₹6,250,000
Compensation

Dr. Rahul Babasaheb Sawakhande is Executive Director of Coherent Medical Systems since July 19, 2024 and serves as its CEO since June 06, 2024. He was Additional Director of Coherent Medical Systems since...


Leadership Team

NamePositionTenureCompensationOwnership
Rahul Sawakhande
CEO & Executive Director1.3yrs₹6.25m4.1%
₹ 48.2m
Dilip Meswani
Founderno data₹1.80m54.16%
₹ 637.2m
Sweta Shah
Chief Financial Officer1.3yrs₹671.00kno data
Anoopkumar Pillai
Company Secretary & Compliance Officerless than a yearno datano data
Rekha Malekar
Human Resource Managerno datano datano data
Deepak Sharma
National Sales Head – Team 22.8yrsno datano data
Saurabh Chamoli
National Sales Head – Team 1no datano datano data
1.3yrs
Average Tenure

Experienced Management: AAKAAR's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Rahul Sawakhande
CEO & Executive Director1.3yrs₹6.25m4.1%
₹ 48.2m
Dilip Meswani
Founder12.3yrs₹1.80m54.16%
₹ 637.2m
Deepanjan Periwal
Independent Directorless than a year₹28.00kno data
Bindi Meswani
Non-Executive Chairperson12.3yrs₹500.00k12.84%
₹ 151.1m
Rajendra Dhandhukia
Independent Directorless than a year₹28.00kno data
1.3yrs
Average Tenure
59yo
Average Age

Experienced Board: AAKAAR's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/06 21:42
End of Day Share Price 2025/10/06 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aakaar Medical Technologies Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.